Central line-associated bloodstream infection prevention

Current Opinion in Infectious Diseases

Volumn 25, Issue 4, 2012, Pages 412-422

  Miller, Sarah E ^a   Maragakis, Lisa L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

central line associated bloodstream infection; chlorhexidine bathing; multifaceted strategy; prevention; technology

Indexed keywords

BENZALKONIUM CHLORIDE; CHLORHEXIDINE GLUCONATE; MINOCYCLINE; RIFAMPICIN; SILVER; SULFADIAZINE SILVER;

ANTIBIOTIC RESISTANCE; ANTISEPSIS; BANDAGE; CANDIDA; CATHETER; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; ENTEROCOCCUS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; PATIENT SAFETY; PRACTICE GUIDELINE; REVIEW; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; ANTISEPSIS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHLORHEXIDINE; EQUIPMENT CONTAMINATION; HUMANS; INFECTION CONTROL; UNITED STATES;

EID: 84863688444     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328355e4da     Document Type: Review

References (76)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating healthcareassociated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007; 122:160-166.
2. Siempos II, Kopterides P, Tsangaris I, et al. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med 2009; 37:2283-2289.
3. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001; 7:174-177. (Pubitemid 32374322)
4. Weeks KR, Goeschel CA, Cosgrove SE, et al. Prevention of central lineassociated bloodstream infections: a journey toward eliminating preventable harm. Curr Infect Dis Rep 2011; 13:343-349.
5. Rosenthal VD, Maki DG, Jamulitrat S, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008. Am J Infect Control 2010; 38:95-104.
6. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008. Am J Infect Control 2009; 37:783-805.
7. Eggimann P, Harbarth S, Constantin MN, et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355:1864-1868. (Pubitemid 30311878)
8. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732. (Pubitemid 46021509)
9. Centers for Disease Control and Prevention (CDC). Reduction in central lineassociated bloodstream infections among patients in intensive care units, Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1013-1016.
10. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014-2020. (Pubitemid 39372534)
11. Pronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010; 340:c309.
12. Weber DJ, Brown VM, Sickbert-Bennett EE, Rutala WA. Sustained and prolonged reduction in central line-associated bloodstream infections as a result of multiple interventions. Infect Control Hosp Epidemiol 2010; 31:875-877.
13. O'Grady NP, Alexander M, Dellinger EP, et al., Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23:759-769. (Pubitemid 36020215)
14. O'Grady NP, Alexander M, Burns LA, et al., Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162-e193.
15. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central lineassociated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1):S22-S30.
16. Million lives campaign getting started kit-how-to guide: prevent central lineassociated bloodstream infection. Cambridge, MA, USA: Institute for Healthcare Improvement, 2006; 26. http://www.ihi.org/IHI/Programs/Campaign/ CentralLineInfection.htm. [Accessed on 27 March 2012]
17. Srinivasan A, Wise M, Bell M, et al. Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011; 60:243-248.
18. National and State Healthcare-Associated Infections Standardized Infection Ratio Report. http://www.cdc.gov/hai/pdfs/SIR/national-SIR-Report-03- 29-2012.pdf. [Accessed on 27 April 2012]
19. U.S. Department of Health and Human Services, HHS action plan to prevent healthcare-associated infections. http://www.hhs.gov/ash/initiatives/hai/ actionplan/. [Accessed on 30 March 2012]
20. The Joint Commission. National patient safety goals. NPSG 7.4.01. http://www.jointcommission.org/assets/1/6/2011-NPSGs-HAP.pdf. [Accessed on 14 April 2012]
21. Centers for Medicare & Medicaid Services. CLABSI quality reporting. Issued November 8, 2010. http://www.aha.org/content/00-10/101109-SDPSmemo. pdf. [Accessed on 25 March 2012]
22. Association for professionals in infection control and epidemiology. Enacted states laws related to infection prevention. http://www.apic.org/ Resource-/TinyMceFileManager/Advocacy-PDFs/Enacted-legis.pdf. Pending legislation. http://www.apic.org/Advocacy/Legislative-Map/Issue-by-legislation. com. [Accessed on 16 April 2012]
23. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140.
24. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332. (Pubitemid 351763841)
25. Guidet B, Nicola I, Barakett V, et al. Skin versus hub cultures to predict colonization and infection of central venous catheter in intensive care patients. Infection 1994; 22:43-48. (Pubitemid 24051843)
26. Salzman MB, Isenberg HD, Shapiro JF, et al. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheterrelated sepsis in neonates. J Infect Dis 1993; 167:487-490. (Pubitemid 23036461)
27. Siegman-Igra Y, Jacobi E, Lang R, et al. Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip. J Hosp Infect 2005; 60:122-128. (Pubitemid 40590579)
28. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. J Infect Dis 1975; 131:267-272.
29. Macias AE, de Leon SP, Huertas M, et al. Endemic infusate contamination and related bacteremia. Am J Infect Control 2008; 36:48-53. (Pubitemid 351172514)
30. Frean JA, Arntzen L, Rosekilly I, Isaacson M. Investigation of contaminated parenteral nutrition fluids associated with an outbreak of Serratia odorifera septicaemia. J Hosp Infect 1994; 27:263-273. (Pubitemid 24265575)
31. Hidron AI, Edwards JR, Patel J, et al., National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996-1011.
32. DePalo VA, McNicoll L, Cornell M, et al. The Rhode Island ICU collaborative: a model for reducing central line-associated bloodstream infection and ventilatorassociated pneumonia statewide. Qual Saf Healthcare 2010; 19:555-561.
33. LinDM,Weeks K,Bauer L, et al. Eradicating central line-associated bloodstream infectionsstatewide:theHawaiiexperience.AmJMedQual2012;27:124-129.
34. Ong A, Dysert K, Herbert C, et al. Trends in central line-associated bloodstream infections in a trauma-surgical intensive care unit. Arch Surg 2011; 146:302-307.
35. McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there yet? Crit Care Med 2012; 40:388-493.
36. Guerin K, Wagner J, Rains K, Bessesen M. Reduction in central lineassociated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control 2010; 38:430-433.
37. Longmate AG, Ellis KS, Boyle L, et al. Elimination of central-venous-catheterrelated bloodstream infections from the intensive care unit. BMJ Qual Saf 2011; 20:174-180.
38. Schulman J, Stricof R, Stevens TP, et al., New York State Regional Perinatal Care Centers. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics 2011; 127:436-444.
39. Wirtschafter DD, Pettit J, Kurtin P, et al. A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. J Perinatol 2010; 30:170-181.
40. Bizzarro MJ, Sabo B, Noonan M, et al., Central Venous Catheter Initiative Committee. A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010; 31:241-248.
41. Rosenthal VD, Ramachandran B, Villamil-Gómez W, et al. Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC). Infection 2012. [Epub ahead of print]
42. Miller MR, Niedner MF, Huskins WC, et al. Reducing PICU central lineassociated bloodstream infections: 3-year results. Pediatrics 2011; 128:e1077-e1083.
43. Khouli H, Jahnes K, Shapiro J, et al. Performance of medical residents in sterile techniques during central vein catheterization: randomized trial of efficacy of simulation-based training. Chest 2011; 139:80-87.
44. Barsuk JH, Cohen ER, Feinglass J, et al. Use of simulation-based education to reduce catheter-related bloodstream infections. Arch Intern Med 2009; 169:1420-1423.
45. Cohen ER, Feinglass J, Barsuk JH, et al. Cost savings from reduced catheterrelated bloodstream infection after simulation-based education for residents in a medical intensive care unit. Simul Health 2010; 5:98-102.
46. Cherry RA, West CE, Hamilton MC, et al. Reduction of central venous catheter associated blood stream infections following implementation of a resident oversight and credentialing policy. Patient Saf Surg 2011; 5:15.
47. Graham AS, Ozment C, Tegtmeyer K, et al. Videos in clinical medicine. Central venous catheterization. N Engl J Med 2007; 356:e21. (Pubitemid 47010844)
48. Comer A, Harris AD, Shardell M, et al., Attaining Safety for Patients through Interdisciplinary Risk Reduction Efforts (ASPIRRE) Subgroup. Web-based training improves knowledge about central line bloodstream infections. Infect Control Hosp Epidemiol 2011; 32:1219-1222.
49. On the CUSP: Stop BSI. National implementation of the comprehensive unitbased safety program to eliminate healthcare-associated infections. Available at: http://www.onthecuspstophai.org/on-the-cuspstop-bsi/. [Accessed on 14 April 2012]
50. Pronovost PJ, Marsteller JA, Goeschel CA. Preventing bloodstream infections: a measurable national success story in quality improvement. Health Aff (Millwood) 2011; 30:628-634.
51. Furuya EY, Dick A, Perencevich EN, et al. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One 2011; 6:e15452.
52. Holzmann-Pazgal G, Kubanda A, Davis K, et al. Utilizing a line maintenance team to reduce central-line-associated bloodstream infections in a neonatal intensive care unit. J Perinatol 2012; 32:281-286.
53. Butler-O'Hara M, D'Angio CT, Hoey H, Stevens TP. An evidence-based catheter bundle alters central venous catheter strategy in newborn infants. J Pediatr 2012; 160:972-977.
54. Taylor T, Massaro A, Williams L, et al. Effect of a dedicated percutaneously inserted central catheter team on neonatal catheter-related bloodstream infection. Adv Neonatal Care 2011; 11:122-128.
55. Barrell C, Covington L, Bhatia M, et al. Preventive strategies for central lineassociated bloodstream infections in pediatric hematopoietic stem cell transplant recipients. Am J Infect Control 2012; 40:434-439.
56. Climo M, Diekema D, Warren DK, et al. Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 2003; 24:942-945. (Pubitemid 38029562)
57. Zingg W, Sax H, Inan C, et al. Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected. J Hosp Infect 2009; 73:41-46.
58. Trick WE, Vernon MO, Welbel SF, et al. Unnecessary use of central venous catheters: the need to look outside the intensive care unit. Infect Control Hosp Epidemiol 2004; 25:266-268. (Pubitemid 38339636)
59. Advani S, Reich NG, Sengupta A, et al. Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis 2011; 52:1108-1115.
60. Marschall J, Leone C, Jones M, et al. Catheter-associated bloodstream infections in general medical patients outside the intensive care unit: a surveillance study. Infect Control Hosp Epidemiol 2007; 28:905-909. (Pubitemid 47218267)
61. Marra AR, Cal RG, Durão MS, et al. Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control 2010; 38:434-439.
62. Gozu A, Clay C, Younus F. Hospital-wide reduction in central line-associated bloodstream infections: a tale of two small community hospitals. Infect Control Hosp Epidemiol 2011; 32:619-622.
63. Bleasdale SC, Trick WE, Gonzales IM, et al. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodsteam infections in medical intensive care unit patients. Arch Intern Med 2007; 167:2073-2079. (Pubitemid 350036706)
64. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009; 37:1858-1865.
65. Dixon JM, Carver RL. Daily chlorhexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections. Am J Infect Control 2010; 38:817-821.
66. O'Horo JC, Silva GL,Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012; 33:257-267.
67. Timsit JF, Dubois Y, Minet C, et al. New materials and devices for preventing catheter-related infections. Ann Intensive Care 2011; 1:34.
68. Timsit JF, Schwebel C, Bouadma L, et al., Dressing Study Group. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009; 301:1231-1241.
69. Ye X, Rupnow M, Bastide P, et al. Economic impact of use of chlorhexidineimpregnated sponge dressing for prevention of central line-associated infections in the United States. Am J Infect Control 2011; 39:647-654.
70. Ramritu P, Halton K, Collignon P, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control 2008; 36:104-117. (Pubitemid 351296068)
71. Casey AL, Mermel LA, Nightingale P, Elliott TS. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8:763-776.
72. Ramos ER, Reitzel R, Jiang Y, et al. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 2011; 39:245-251.
73. Maki DG, Ash SR, Winger RK, Lavin P, AZEPTIC Trial Investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multicenter, controlled, randomized trial. Crit Care Med 2011; 39:613-620.
74. John BK, Khan MA, Speerhas R, et al. Ethanol lock therapy in reducing catheter-related bloodstream infections in adult home parenteral nutrition patients: results of a retrospective study. JPEN J Parenter Enteral Nutr 2011. [Epub ahead of print]
75. Jones BA, Hull MA, Richardson DS, et al. Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure. J Pediatr Surg 2010; 45:1287-1293.
76. Slobbe L, Doorduijn JK, Lugtenburg PJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunneled catheters: a randomized, placebo-controlled trial. PLoS One 2010; 5:e10840.